.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
QuintilesIMS
Daiichi Sankyo
Fish and Richardson
Johnson and Johnson
Deloitte
Julphar
Accenture
Teva

Generated: November 20, 2017

DrugPatentWatch Database Preview

DURAGESIC-100 Drug Profile

« Back to Dashboard

What is the patent landscape for Duragesic-100, and what generic Duragesic-100 alternatives are available?

Duragesic-100 is a drug marketed by Janssen Pharms and is included in one NDA.

The generic ingredient in DURAGESIC-100 is fentanyl. There are thirty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the fentanyl profile page.

Pharmacology for DURAGESIC-100

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

Medical Subject Heading (MeSH) Categories for DURAGESIC-100

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms
DURAGESIC-100
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL019813-001Aug 7, 1990ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DURAGESIC-100

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
DURAGESIC-100
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL019813-001Aug 7, 1990► Subscribe► Subscribe
Janssen Pharms
DURAGESIC-100
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL019813-001Aug 7, 1990► Subscribe► Subscribe
Janssen Pharms
DURAGESIC-100
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL019813-001Aug 7, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
McKinsey
Healthtrust
Argus Health
Teva
Citi
Boehringer Ingelheim
Merck
Fuji
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot